Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.41
+0.00870.62%
Volume:20.37K
Turnover:28.42K
Market Cap:34.23M
PE:-6.74
High:1.42
Open:1.40
Low:1.39
Close:1.40
52wk High:5.48
52wk Low:0.6100
Shares:24.30M
Float Shares:21.54M
Volume Ratio:2.67
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2089
EPS(LYR):-0.4200
ROE:-47.71%
ROA:-17.22%
PB:2.84
PE(LYR):-3.35

Loading ...

Jun 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Apr 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 15, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 24, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 17, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Major Issues Report

8-K - Current report
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]